Abiopharma

🔍 Balance Austin J (Executive)

Company: Grindr Inc. (GRND)

Report Date: 2026-08-31

Detailed Transactions and Holdings:

• Acquired 26,304 shares of Common Stock at $4.2 per share (Direct)
  Date: 2026-08-31 | Code: M | equity_swap_involved: 0 | shares_owned_after: 939,694.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 89,638 shares of Common Stock at $15.46 per share (Direct)
  Date: 2026-08-31 | Code: S | equity_swap_involved: 0 | shares_owned_after: 850,056.00 | transaction_form_type: 4 | Footnotes: F2, F3
• Sold 26,304 shares of Stock Option (right to buy) at $4.2 per share (Derivative)
  Date: 2026-08-31 | Code: M | Expires: 2028-12-07 | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F1, F4

Footnotes:

• F1: The option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan, adopted on June 1, 2026.
• F2: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan, adopted on June 1, 2026.
• F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.26 to $15.61, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
• F4: The stock option award was granted to the Reporting Person on December 7, 2021, and initially represented a right to purchase a total of 420,881 shares upon vesting. 1/12 of the shares subject to the stock option vested on December 3, 2022, and 1/12 of the shares vested quarterly thereafter.